(NASDAQ: BNGO) Bionano Genomics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 71.21%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 59.2%.
Bionano Genomics's earnings in 2025 is -$135,783,000.On average, 1 Wall Street analyst forecast BNGO's earnings for 2025 to be -$52,016,545, with the lowest BNGO earnings forecast at -$52,016,545, and the highest BNGO earnings forecast at -$52,016,545.
In 2026, BNGO is forecast to generate -$37,737,493 in earnings, with the lowest earnings forecast at -$37,737,493 and the highest earnings forecast at -$37,737,493.